Valuation: Solventum Corporation

Market Cap 14.52B 12.59B 11.82B 10.76B 20.22B 1,385B 20.56B 139B 54.23B 694B 54.5B 53.32B 2,316B P/E 2026 *
47.3x
P/E 2027 * 24.2x
Enterprise Value 19.8B 17.17B 16.12B 14.68B 27.57B 1,889B 28.04B 189B 73.95B 947B 74.31B 72.7B 3,158B EV / Sales 2026 *
2.41x
EV / Sales 2027 * 2.29x
Free-Float
82.36%
Yield 2026 *
-
Yield 2027 * -
1 day+1.37%
1 week-1.15%
Current month+1.19%
1 month+12.72%
3 months+15.13%
6 months+13.84%
Current year+9.11%
1 week 81.22
Extreme 81.22
86.81
1 month 75.55
Extreme 75.55
90
Current year 62.38
Extreme 62.38
90
1 year 62.38
Extreme 62.38
90
3 years 47.16
Extreme 47.16
96.05
5 years 47.16
Extreme 47.16
96.05
10 years 47.16
Extreme 47.16
96.05
Date Insider Type Main position Quantity % Market Cap.
4/30/26 Fiscal year

Chairman

9,832 0.0057%
3/27/26 Fiscal year

Chairman

12,672 0.0073%
3/5/26 Fiscal year

Chief Financial Officer

55,711 0.0321%
Change 5-day change 1-year change 3-year change Capi.($)
+1.37%-1.15%+19.93% - 14.52B
+0.32%+5.26%-15.07%+5.66% 192B
-0.20%+5.34%-1.63%+8.54% 116B
-1.32%-2.27%+7.21%+65.45% 59.95B
+2.11%+2.55%+34.34%+62.10% 54.64B
-0.88%+6.63%-6.66%-35.54% 50B
+0.75%+10.67%+14.11%-18.09% 34.26B
+0.23%-2.96% - - 31.15B
-1.74%-1.38%+44.29%-12.31% 24.79B
+0.85%+14.53%-3.89%+20.23% 24.07B
Average +0.15%+3.56%+10.29%+12.01% 60.15B
Weighted average by Cap. +0.08%+4.11%+1.18%+12.92%

Financials

2026 *2027 *
Net sales 8.23B 7.14B 6.7B 6.1B 11.46B 785B 11.65B 78.57B 30.73B 393B 30.89B 30.22B 1,312B 8.51B 7.38B 6.93B 6.31B 11.86B 812B 12.06B 81.3B 31.8B 407B 31.96B 31.27B 1,358B
Net income 318M 276M 259M 236M 443M 30.38B 451M 3.04B 1.19B 15.23B 1.2B 1.17B 50.79B 601M 522M 490M 446M 838M 57.4B 852M 5.74B 2.25B 28.76B 2.26B 2.21B 95.95B
Net Debt 5.28B 4.58B 4.3B 3.91B 7.35B 504B 7.48B 50.4B 19.72B 252B 19.81B 19.38B 842B 4.95B 4.29B 4.03B 3.67B 6.89B 472B 7.01B 47.27B 18.49B 237B 18.58B 18.18B 790B
Logo Solventum Corporation
Solventum Corporation specializes in the marketing of tools used in the medical field. Net sales break down by family of products as follows: - medical instruments and accessories (56.2%): for wound care, sterilization, surgery, etc.; - medical information systems (15.8%): including software solutions for documentation, billing, coding, data visualization, etc. in hospital environments; - dental and orthodontic instruments and accessories (15.7%): for dental care and restoration; - purification and filtration instruments (11.6%): used in the medical, bio-pharmaceutical, agri-food and other sectors; - other (0.7%). The United States accounts for 57.5% of net sales.
Employees
20,584
Date Price Change Volume
26-08-13 US$86.46 +1.37% 1,232,072
26-08-12 US$85.29 +1.41% 833,980
26-08-11 US$84.10 -1.30% 773,865
26-08-10 US$85.21 +2.69% 1,400,390
26-08-07 US$82.98 +0.02% 1,104,147
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
85.29USD
Average target price
93.92USD
Spread / Average Target
+10.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SOLV Stock